Progression of macular atrophy after PDT combined with the COX-2 inhibitor Nabumetone in the treatment of neovascular ARMD.

Sin, Martin; Chrapek, Oldrich; Karhanova, Marta; Pracharova, Zuzana; Langova, Katerina; Rehak, Jiri

Sin, Martin; Chrapek, Oldrich; Karhanova, Marta; Pracharova, Zuzana; Langova, Katerina; Rehak, Jiri.

Affiliation

Sin M; Department of Ophthalmology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub ; 158(1): 138-43, 2014.

Article in En | MEDLINE | ID: mdl-23132511

Subject(s)

Butanones/therapeutic use; Cyclooxygenase 2 Inhibitors/therapeutic use; Macula Lutea/pathology; Macular Degeneration/drug therapy; Neovascularization, Pathologic/drug therapy; Photochemotherapy; Photosensitizing Agents/therapeutic use; Porphyrins/therapeutic use; Aged; Aged, 80 and over; Atrophy; Choroid/blood supply; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Macular Degeneration/pathology; Male; Nabumetone; Prospective Studies; Verteporfin; Visual Acuity

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Photochemotherapy / Porphyrins / Butanones / Photosensitizing Agents / Cyclooxygenase 2 Inhibitors / Macula Lutea / Macular Degeneration / Neovascularization, Pathologic Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Journal subject: MEDICINA Year: 2014 Document type: Article Affiliation country: Czech Republic Country of publication: Czech Republic

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google